Two Sigma Advisers
URGN icon

Two Sigma Advisers’s UroGen Pharma URGN Stock Holding History

Two Sigma Advisers’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-111,600
Closed -$2.23M – 2638
2025
Q3 		$2.23M Buy
+111,600
New +$2M ﹤0.01% 1098
2024
Q4 		– Sell
-24,500
Closed -$311K – 2541
2024
Q3 		$311K Sell
24,500
-400
-2% -$5.94K ﹤0.01% 1894
2024
Q2 		$418K Buy
24,900
+6,100
+32% +$86.8K ﹤0.01% 1957
2024
Q1 		$282K Buy
18,800
+500
+3% +$8.17K ﹤0.01% 2093
2023
Q4 		$275K Sell
18,300
-600
-3% -$7.79K ﹤0.01% 2132
2023
Q3 		$265K Buy
+18,900
New +$303K ﹤0.01% 2018
2019
Q2 		– Sell
-8,800
Closed -$325K – 2444
2019
Q1 		$325K Buy
8,800
+1,800
+26% +$75.5K ﹤0.01% 1961
2018
Q4 		$301K Sell
7,000
-1,100
-14% -$49.5K ﹤0.01% 1984
2018
Q3 		$383K Sell
8,100
-2,100
-21% -$97.6K ﹤0.01% 1893
2018
Q2 		$508K Buy
+10,200
New +$594K ﹤0.01% 1911

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return